Six Companies Worthy of Note in AI Drug Discovery
BenevolentAI faces challenges with CEO departure and halted program; BioXcel advances BXCL501 in agitation treatments; BullFrog AI shows potential in liver disease and neuropsychiatric conditions; Iktos leverages AI for drug discovery; Jura Bio introduces Variational Synthesis for protein manufacturing; Phare Bio secures funding for AI-driven antibiotic discovery.
© Copyright 2025. All Rights Reserved by MedPath